Quebec platelet disorder: Difference between revisions
CSV import |
CSV import |
||
| Line 27: | Line 27: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Autosomal_dominant_-_en.svg|Autosomal dominant inheritance pattern | |||
</gallery> | |||
Revision as of 21:36, 20 February 2025
Quebec Platelet Disorder (QPD) is a rare bleeding disorder that is characterized by a deficiency in the blood platelets' ability to clot. This disorder is unique to certain families in the province of Quebec, Canada, hence its name.
Symptoms
The symptoms of Quebec Platelet Disorder include bruising, nosebleeds, gastrointestinal bleeding, and menorrhagia (heavy menstrual bleeding). These symptoms are due to the inability of the blood platelets to clot properly, leading to excessive bleeding.
Causes
Quebec Platelet Disorder is caused by a mutation in the gene that codes for the production of plasminogen activator inhibitor-1 (PAI-1), a protein that inhibits the breakdown of blood clots. This mutation results in an overproduction of PAI-1, leading to a decrease in the ability of the blood platelets to clot.
Diagnosis
The diagnosis of Quebec Platelet Disorder is based on the presence of the characteristic symptoms, a family history of the disorder, and laboratory tests that show an increase in the level of PAI-1 in the blood.
Treatment
The treatment of Quebec Platelet Disorder is aimed at controlling the symptoms and preventing bleeding episodes. This may include the use of antifibrinolytic drugs, which help to stabilize blood clots and prevent them from breaking down.
See also
References
<references />


